期刊文献+
共找到181篇文章
< 1 2 10 >
每页显示 20 50 100
Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report 被引量:4
1
作者 Su Lin Tian-Yu Shang +7 位作者 Ming-Fang Wang Jian Lin Xiao-Jian Ye Da-Wu Zeng Jiao-Feng Huang Nan-Wen Zhang Yi-Long Wu Yue-Yong Zhu 《World Journal of Clinical Cases》 SCIE 2018年第9期296-300,共5页
Von Meyenburg complexes(VMCs) are a rare type of ductal plate malformation. We herein report two Chinese families with VMCs, and the suspicious gene mutation of this disease. Proband A was a 62-year-old woman with abn... Von Meyenburg complexes(VMCs) are a rare type of ductal plate malformation. We herein report two Chinese families with VMCs, and the suspicious gene mutation of this disease. Proband A was a 62-year-old woman with abnormal echographic presentation of the liver. She received magnetic resonance imaging(MRI) examination and liver biopsy, and the results showed she had VMCs. Histologically proved hepatocellular carcinoma was found 1 year after the diagnosis of VMCs. Proband B was a 57-year-old woman with intrahepatic diffuselesions displayed by abdominal ultrasonography. Her final diagnoses were VMCs, congenital hepatic fibrosis, and hepatitis B surface e antigen-negative chronic hepatitis B after a series of examinations. Then, all the family members of both proband A and proband B were screened for VMCs by MRI or ultrasonography. The results showed that four of the 11 family members from two families, including two males and two females, were diagnosed with VMCs. DNA samples were extracted from the peripheral blood of those 11 individuals of two VMCs pedigrees and subjected to polymerase chain reaction amplification of the polycystic kidney and hepatic disease 1(PKHD1) gene. Two different mutation loci were identified. Heterozygous mutations located in exon 32(c.4280 delG, p.Gly1427 ValfsX 6) in family A and exon 28(c.3118 C>T, p.Arg1040 Ter) in family B were detected. We speculate that PKHD1 gene mutations may be responsible for the development of VMCs. 展开更多
关键词 Von Meyenburg complexES DUCTAL PLATE MALFORMATIONS PKHD1 Gene mutation FIBROSIS
暂未订购
Effect of the mutation of carotenoids on the dynamics of energy transfer in light-harvesting complexes (LH2) from Rhodobacter sphaeroides 601 at room temperature
2
作者 刘伟民 刘源 +4 位作者 刘康俊 闫永丽 郭立俊 徐春和 钱士雄 《Chinese Physics B》 SCIE EI CAS CSCD 2006年第8期1725-1730,共6页
Energy transfers in two kinds of peripheral light-harvesting complexes (LH2) of Rhodobacter sphaeroides (RS) 601 are studied by using femtosecond pump^probe spectroscopy with tunable laser wavelength at room tempe... Energy transfers in two kinds of peripheral light-harvesting complexes (LH2) of Rhodobacter sphaeroides (RS) 601 are studied by using femtosecond pump^probe spectroscopy with tunable laser wavelength at room temperature. These two complexes are native LH2 (RS601) and green carotenoid mutated LH2 (GM309). The obtained results demonstrate that, compared with spheroidenes with ten conjugated double bonds in native RS601, carotenoid in GM309 containing neurosporenes with nine conjugated double bonds can lead to a reduction in energy transfer rate in the B800-to-B850 band and the disturbance in the energy relaxation processes within the excitonic B850 band. 展开更多
关键词 light harvesting complex (LH2) carotenoid mutation energy transfer femtosecond pumpprobe
原文传递
Recombination and mutation shape variations in the major histocompatibility complex
3
作者 Yuying Sun Fang Yuan +7 位作者 Ling Wang Dongfa Dai Zhijian Zhang Fei Liang Nan Liu Juan Long Xiao Zhao Yongzhi xi 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2022年第12期1151-1161,共11页
The major histocompatibility complex(MHC)is closely associated with numerous diseases,but its high degree of polymorphism complicates the discovery of disease-associated variants.In principle,recombination and de novo... The major histocompatibility complex(MHC)is closely associated with numerous diseases,but its high degree of polymorphism complicates the discovery of disease-associated variants.In principle,recombination and de novo mutations are two critical factors responsible for MHC polymorphisms.However,direct evidence for this hypothesis is lacking.Here,we report the generation of fine-scale MHC recombination and de novo mutation maps of~5 Mb by deep sequencing(>100×)of the MHC genome for 17 MHC recombination and 30 non-recombination Han Chinese families(a total of 190 individuals).Recombination hotspots and Han-specific breakpoints are located in close proximity at haplotype block boundaries.The average MHC de novo mutation rate is higher than the genome-wide de novo mutation rate,particularly in MHC recombinant individuals.Notably,mutation and recombination generated polymorphisms are located within and outside linkage disequilibrium regions of the MHC,respectively,and evolution of the MHC locus was mainly controlled by positive selection.These findings provide insights on the evolutionary causes of the MHC diversity and may facilitate the identification of disease-associated genetic variants. 展开更多
关键词 Major histocompatibility complex(MHC) Recombination De novo mutation Positive selection Disease-associated genetic variants
原文传递
Complex heterozygous mutations in hereditary spherocytosis:A case report
4
作者 Miao He Yan-Cheng Lv +3 位作者 Yu-Hong Wei Lan-Qin Liu Ling Guo Cheng Li 《World Journal of Clinical Cases》 SCIE 2024年第18期3582-3588,共7页
BACKGROUND The aim of this study was to investigate the complex heterozygous mutations of ANK1 and SPTA1 in the same individual and improve our understanding of hereditary spherocytosis(HS)in children.We also hope to ... BACKGROUND The aim of this study was to investigate the complex heterozygous mutations of ANK1 and SPTA1 in the same individual and improve our understanding of hereditary spherocytosis(HS)in children.We also hope to promote the application of gene detection technology in children with HS,with the goals of identifying more related gene mutations,supporting the acquisition of improved molecular genetic information to further reveal the pathogenesis of HS in children,and providing important guidance for the diagnosis,treatment,and prevention of HS in children.CASE SUMMARY A 1-year and 5-month-old patient presented jaundice during the neonatal period,mild anemia 8 months later,splenic enlargement at 1 year and 5 months,and brittle red blood cell permeability.Genetic testing was performed on the patient,their parents,and sister.Swiss Model software was used to predict the protein structure of complex heterozygous mutations in ANK1 and SPTA1.Genetic testing revealed that the patient harbored a new mutation in the ANK1 gene from the father and a mutation in the SPTA1 gene from the mother.Combined with the clinical symptoms of the children,it is suggested that the newly discovered complex heterozygous mutations of ANK1 and SPTA1 may be the cause,providing important guidance for revealing the pathogenesis,diagnosis,treatment,and promotion of gene detection technology in children with HS.CONCLUSION This case involves an unreported complex heterozygous mutation of ANK1 and SPTA1,which provides a reference for exploring HS. 展开更多
关键词 Hereditary spherocytosis complex heterozygous mutations ANK1 SPTA1 Gene detection technology Case report
暂未订购
Complete mitochondrial DNA sequence analysis in two southern Chinese pedigrees with Leber hereditary optic neuropathy revealed secondary mutations along with the primary mutation 被引量:5
5
作者 Lei Shu Yong-Ming Zhang +2 位作者 Xiao-Xiao Huang Chun-Yue Chen Xian-Ning Zhang 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2012年第1期28-31,共4页
AIM: To investigate mitochondrial factors associated with Leber hereditary optic neuropathy (LHON) through complete sequencing and analysis of the mitochondrial genome of Chinese patients with this disease. METHODS: T... AIM: To investigate mitochondrial factors associated with Leber hereditary optic neuropathy (LHON) through complete sequencing and analysis of the mitochondrial genome of Chinese patients with this disease. METHODS: Two unrelated southern Chinese families with LHON and 10 matched healthy controls were recruited, and their entire mitochondrial DNA (mtDNA) was amplified and sequenced with the universal M13 primer. Then DNA sequence analysis and variation identification were performed by DNAssist and Chromas 2 software and compared with authoritative databases such as Mitomap. RESULTS: Mutational analysis of mtDNA in these two Chinese pedigrees revealed one common LHON-associated mutation, G11778A (Arg -> His), in the MT-ND4 gene. In addition, there were two secondary mutations in Pedigree 1: C34971 (Ala -> Val), and C3571T (Leu -> Phe) in the MT-ND1 gene, which have not been reported; and two secondary mutations occurred in Pedigree 2: A10398G (Thr -> Ala) in the MT-ND3 gene, and T14502C (Ile -> Val) in the MT-ND6 gene. Three polymorphisms, A73G, G94A and A263G in the mtDNA control region, were also found. CONCLUSION: Our study confirmed that the known MT-ND4* G11778A mutation is the most significant cause of LHON. The C3497T and C3571T mutations in Pedigree 1 were also both at hot-spots of MT-ND1; they may affect the respiratory chain in coordination with the primary mutation G11778A. In Pedigree 2, the two secondary mutations A10398G of MT-ND3 and T14502C of MT-ND6 may influence mitochondrial respiratory complex I, leading to the mitochondrial respiratory chain dysfunction which results in optic atrophy together with G11778A. Therefore, not only the common primary LHON mutation is responsible for the visual atrophy, but other secondary mtDNA mutations should also be considered when giving genetic counseling. 展开更多
关键词 Leber hereditary optic neuropathy mitochondrial DNA mutation mitochondrial respiratory complex I
原文传递
Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients Harboring Different Types of EGFR Mutations:A Retrospective Analysis 被引量:8
6
作者 刘华丽 韩光 +5 位作者 彭敏 翁一鸣 袁静萍 杨桂芳 于金明 宋启斌 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2017年第6期864-872,共9页
With the development of molecular pathology, many types of epidermal growth factor receptor(EGFR) mutations have been identified. The efficacy of EGFR tyrosine kinase inhibitors(EGFR-TKIs) in non-small cell lung c... With the development of molecular pathology, many types of epidermal growth factor receptor(EGFR) mutations have been identified. The efficacy of EGFR tyrosine kinase inhibitors(EGFR-TKIs) in non-small cell lung cancer(NSCLC) patients with different types of EGFR mutations, especially in patients with single rare mutations or complex mutations(co-occurrence of two or more different mutations), has not been fully understood. This study aimed to examine the efficacy of EGFR-TKIs in NSCLC patients with different types of EGFR mutations. Clinical data of 809 NSCLC patients who harbored different types of EGFR mutations and treated from January 2012 to October 2016 at Renmin Hospital and Zhongnan Hospital, Wuhan, were retrospectively reviewed. The clinical characteristics of these patients and the efficacy of EGFR-TKIs were analyzed. Among these patients, 377 patients had only the EGFR del-19 mutation, 362 patients the EGFR L858R mutation in exon 21, 33 patients single rare mutations and 37 patients complex mutations. Among these 809 patients, 239 patients were treated with EGFR-TKIs. In all the 239 patients, the disease control rate(DCR) was 93.7% with two patients(0.2%) achieving complete response(CR), the median progression free survival(PFS) was 13.0 months(95% confidence interval [CI], 11.6–14.4 months), and the median overall survival(OS) was 55.0 months(95% CI, 26.3–83.7 months). Subgroup analysis revealed that the DCR in patients harboring single rare or complex mutations of EGFR was significantly lower than in those with del-19 or L858 R mutation(P〈0.001). Patients with classic mutations(del-19 and/or L858 R mutations) demonstrated longer PFS(P〈0.001) and OS(P=0.017) than those with uncommon mutations(single rare and/or complex mutations). Furthermore, the patients with single rare mutations had shorter median OS than in those with other mutations. Multivariate Cox regression analysis identified that the type of EGFR mutations was an independent risk factor for PFS(hazard ratio [HR]=0.308, 95% CI, 0.191–0.494, P〈0.001) and OS(HR=0.221, 95% CI, 0.101–0.480, P〈0.001). The results suggest that the single rare or complex EGFR mutations confer inferior efficacy of EGFR-TKIs treatment to the classic mutations. The prognosis of the single rare EGFR mutations is depressing. EGFR-TKIs may be not a good choice for NSCLC patients with single rare mutations of EGFR. Further studies in these patients with uncommon mutations(especially for the patients with single rare mutations) are needed to determine a better precision treatment. 展开更多
关键词 non-small cell lung cancer epidermal growth factor receptor rare mutations complex mutations tyrosine kinase inhibitors
暂未订购
Mutation of MED12 is not a frequent occurrence in prostate cancer of Korean patients
7
作者 Nara Yoon Sharon Lim +7 位作者 So Young Kang Ghee Young Kwon Hwang Gyun Jeon Byong Chang Jeong Seong Il Seo Seong Soo Jeon Hyun Moo Lee Han Yong Choi 《Asian Journal of Andrology》 SCIE CAS CSCD 2017年第3期346-349,共4页
Prostate cancer is one of the major health care problems, but the molecular pathogenesis has been relatively insufficiently elucidated. Recently, whole exome sequencing of prostate cancer identified recurrent mutation... Prostate cancer is one of the major health care problems, but the molecular pathogenesis has been relatively insufficiently elucidated. Recently, whole exome sequencing of prostate cancer identified recurrent mutations involving MED12 in Caucasian patients, which finding was not reproduced in one subsequent study by Sanger sequencing. Thus, we investigated mutation status of MED12 in exons 2 and 26 by Sanger sequencing in 102 radical prostatectomy cases from Korean patients. The analysis found the mutation in none of the cases. Therefore, MED12 mutation does not appear to represent a significant molecular alteration in this cohort of patients according to the analysis by the traditional "gold standard." 展开更多
关键词 mediator complex subunit 12 mutation analysis prostate cancer prostate neoplasms
原文传递
Presenilin mutations and their impact on neuronal differentiation in Alzheimer’s disease
8
作者 Mercedes A.Hernández-Sapiéns Edwin E.Reza-Zaldívar +6 位作者 Ana L.Márquez-Aguirre Ulises Gómez-Pinedo Jorge Matias-Guiu Ricardo R.Cevallos Juan C.Mateos-Díaz Víctor J.Sánchez-González Alejandro A.Canales-Aguirre 《Neural Regeneration Research》 SCIE CAS CSCD 2022年第1期31-37,共7页
The presenilin genes(PSEN1 and PSEN2)are mainly responsible for causing early-onset familial Alzheimer’s disease,harboring~300 causative mutations,and representing~90%of all mutations associated with a very aggressiv... The presenilin genes(PSEN1 and PSEN2)are mainly responsible for causing early-onset familial Alzheimer’s disease,harboring~300 causative mutations,and representing~90%of all mutations associated with a very aggressive disease form.Presenilin 1 is the catalytic core of theγ-secretase complex that conducts the intramembranous proteolytic excision of multiple transmembrane proteins like the amyloid precursor protein,Notch-1,N-and E-cadherin,LRP,Syndecan,Delta,Jagged,CD44,ErbB4,and Nectin1a.Presenilin 1 plays an essential role in neural progenitor maintenance,neurogenesis,neurite outgrowth,synaptic function,neuronal function,myelination,and plasticity.Therefore,an imbalance caused by mutations in presenilin 1/γ-secretase might cause aberrant signaling,synaptic dysfunction,memory impairment,and increased Aβ42/Aβ40 ratio,contributing to neurodegeneration during the initial stages of Alzheimer’s disease pathogenesis.This review focuses on the neuronal differentiation dysregulation mediated by PSEN1 mutations in Alzheimer’s disease.Furthermore,we emphasize the importance of Alzheimer’s disease-induced pluripotent stem cells models in analyzing PSEN1 mutations implication over the early stages of the Alzheimer’s disease pathogenesis throughout neuronal differentiation impairment. 展开更多
关键词 familial Alzheimer’s disease familial Alzheimer’s disease-induced pluripotent stem cells models induced pluripotent stem cells neurogenesis neuronal differentiation Notch presenilin 1 PSEN1 mutations γ-secretase complex
暂未订购
Genetic complexity underlies clinical heterogeneity:YWTDβ-propeller mutations and second-hit modifier mutations in LRP6-related tooth agenesis and ectodermal dysplasia in human
9
作者 Xinxin Dong Miao Yu +7 位作者 Zhaoyang Jia Jinye Bai Jing Zhang Shengnan Ling Limin Guan Yi Lu Dong Han Xiwen Gu 《Genes & Diseases》 2025年第6期42-46,共5页
Hereditary disorders often present remarkable genetic and clinical heterogeneities,but bridging the gap between pathogenic mutation and clinical consequences remains challenging.One plausible explanation is the presen... Hereditary disorders often present remarkable genetic and clinical heterogeneities,but bridging the gap between pathogenic mutation and clinical consequences remains challenging.One plausible explanation is the presence of second-hit modifier mutations,which could create additional genetic complexity to contribute to clinical heterogeneities. 展开更多
关键词 clinical heterogeneities genetic clinical heterogeneitiesbut hereditary disorders bridging gap pathogenic mutation clinical consequences ywtd propeller mutations second hit modifier mutations genetic complexity clinical heterogeneity
原文传递
Exploring Biocomplexity in Cancer: A Comprehensive Review
10
作者 Andras Szasz Gyula Peter Szigeti 《Open Journal of Biophysics》 2024年第2期154-238,共85页
Living objects have complex internal and external interactions. The complexity is regulated and controlled by homeostasis, which is the balance of multiple opposing influences. The environmental effects finally guide ... Living objects have complex internal and external interactions. The complexity is regulated and controlled by homeostasis, which is the balance of multiple opposing influences. The environmental effects finally guide the self-organized structure. The living systems are open, dynamic structures performing random, stationary, stochastic, self-organizing processes. The self-organizing procedure is defined by the spatial-temporal fractal structure, which is self-similar both in space and time. The system’s complexity appears in its energetics, which tries the most efficient use of the available energies;for that, it organizes various well-connected networks. The controller of environmental relations is the Darwinian selection on a long-time scale. The energetics optimize the healthy processes tuned to the highest efficacy and minimal loss (minimalization of the entropy production). The organism is built up by morphogenetic rules and develops various networks from the genetic level to the organism. The networks have intensive crosstalk and form a balance in the Nash equilibrium, which is the homeostatic state in healthy conditions. Homeostasis may be described as a Nash equilibrium, which ensures energy distribution in a “democratic” way regarding the functions of the parts in the complete system. Cancer radically changes the network system in the organism. Cancer is a network disease. Deviation from healthy networking appears at every level, from genetic (molecular) to cells, tissues, organs, and organisms. The strong proliferation of malignant tissue is the origin of most of the life-threatening processes. The weak side of cancer development is the change of complex information networking in the system, being vulnerable to immune attacks. Cancer cells are masters of adaptation and evade immune surveillance. This hiding process can be broken by electromagnetic nonionizing radiation, for which the malignant structure has no adaptation strategy. Our objective is to review the different sides of living complexity and use the knowledge to fight against cancer. 展开更多
关键词 complexity Networks SMALL-WORLD Genetic mutations SELF-ORGANIZING Self-Symmetry Energetic Balance Entropy Nash Equilibrium GAMES Evolution CANCER Therapy
暂未订购
A Chinese Tuberous Sclerosis Complex Family and a Novel Tuberous Sclerosis Complex-2 Mutation 被引量:5
11
作者 Rong Luo Qianyun Cai Dezhi Mu 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第1期128-130,共3页
Tuberous sclerosis complex (TSC) is a relatively common autosomal dominant genetic disorder affecting l/14,000-1/6000 Western populations.The incidence of TSC in Chinese population is still unknown although case rep... Tuberous sclerosis complex (TSC) is a relatively common autosomal dominant genetic disorder affecting l/14,000-1/6000 Western populations.The incidence of TSC in Chinese population is still unknown although case reports of Chinese TSC patients were documented. The main clinical features of TSC include seizures,mental retardation,and the development ofhamartomas in multiple organs such as the skin,brain,lung,heart,and kidney.Indeed,the disease virtually manifests in every organ. Two causative genes for TSC,TSC 1 gene on chromosome 9q34 and TSC2 gene on chromosome16p13,have been identified in 1997 and 1993 respectively.Approximately,70% of cases of TSC are de novo mutations. Chinese TSC patients are more likely to have TSC2 missense and frame shift mutations.Here,we record one Chinese TSC family and it is novel frame shift mutation of TSC2. 展开更多
关键词 Tuberous Sclerosis complex Gene mutation TSC2
原文传递
A Novel Mutation of PRKAR1A Caused Carney Complex in a Chinese Patient 被引量:2
12
作者 Xiao-Ling Cai Jing Wu +3 位作者 Ying-Ying Luo Ling Chen Xue-Yao Han Li-Nong Ji 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第24期3009-3010,共2页
Primary pigmented nodular adrenocortical disease (PPNAD) causes adrenocorticotropic hormone (ACTH)-independent Cushing's syndrome (CS),which is the most frequent endocrine manifestation of Carney complex (CNC... Primary pigmented nodular adrenocortical disease (PPNAD) causes adrenocorticotropic hormone (ACTH)-independent Cushing's syndrome (CS),which is the most frequent endocrine manifestation of Carney complex (CNC).[1] In the disease process of PPNAD,both presadrenal glands are involved and feature small brown-black nodules separated by the atrophic adrenal cortex. 展开更多
关键词 Carney complex CHINESE mutation PRKAR1A Gene
原文传递
SMARCA4缺失型肺恶性肿瘤的临床病理学特征及患者预后分析
13
作者 常珂晟 邵瑾 +1 位作者 张琪 刘益飞 《中国癌症杂志》 北大核心 2025年第12期1108-1118,共11页
背景和目的:关于SWI/SNF染色质重塑复合物(switch/sucrose nonfermentable)缺失的肺恶性肿瘤的研究,特别是SMARCA4缺失型未分化肿瘤(SMARCA4-deficient undifferentiated tumor,SD-UT)与低分化非小细胞肺癌(non-small cell lung cancer,... 背景和目的:关于SWI/SNF染色质重塑复合物(switch/sucrose nonfermentable)缺失的肺恶性肿瘤的研究,特别是SMARCA4缺失型未分化肿瘤(SMARCA4-deficient undifferentiated tumor,SD-UT)与低分化非小细胞肺癌(non-small cell lung cancer,NSCLC)的鉴别标准,目前仍然有限。本研究旨在为临床鉴别SMARCA4缺失型低分化NSCLC及SD-UT并判断其预后提供依据。方法:回顾性分析2016—2023年于无锡市第二人民医院手术切除的肺恶性肿瘤患者,满足以下纳入条件:(1)经组织病理学检查确诊的肺腺癌,以及无任何具有明确特异性分化(如鳞癌、神经内分泌癌等)的未分化肿瘤;(2)拥有足够组织用于免疫组织化学染色检测及基因检测;(3)需有完整随访资料。统计学方法包括log-rank检验、Fisher精确概率检验、Wilcoxon秩和检验等。研究的主要观察指标为总生存期,即从患者确诊日期至因任何原因死亡日期或末次随访日期的时间间隔。本研究获无锡市第二人民医院伦理委员会的批准[(2025)伦理审查第(Y-58)号]。结果:本研究共纳入485例患者,其中有47例SMARCA4完全缺失/弱阳性,包括15例高/中分化、22例低分化NSCLC和10例UT。UT在形态学上与低分化NSCLC存在显著重叠,但SD-UT中横纹肌样肿瘤细胞比例较高。3组性别(男性占46.67%、90.91%和100%,P=0.002)及肿瘤大小(中位直径2.0 cm、3.5 cm和2.6 cm,P=0.030)、分期(Ⅲ~Ⅳ期占0%、45.45%和60.00%,P<0.001)差异有统计学意义。高-中分化SD-NSCLC、低分化SD-NSCLC患者的中位随访时间分别为59、40个月,SD-UT患者平均随访18.6个月。生存分析显示,438例表达SMARCA4的NSCLC患者生存率与15例高/中分化SD-NSCLC患者差异无统计学意义;SD-UT患者(中位生存期20个月,生存率为0%)的预后显著差于低分化NSCLC患者(中位生存期56个月,生存率为18.52%)(P=0.022,χ^(2)=5.252)。log-rank检验结果显示,AE1/AE3(阳性25例,阴性7例,P=0.022)、SMARCA2(阳性29例,阴性3例,P=0.362)的表达与预后显著相关,而与Claudin-4(阳性27例,阴性5例,P=0.561)的表达相关性不显著。在低分化SD-NSCLC与SD-UT患者中,接受免疫治疗的患者其总生存期较未接受者获得显著改善(P=0.036)。结论:SMARCA4缺失与患者性别及肿瘤侵袭性相关。AE1/AE3、SMARCA2、Claudin-4与预后的相关性为SMARCA4缺失型肿瘤的分类提供了新标准。免疫治疗在SD患者中效果良好。 展开更多
关键词 肺恶性肿瘤 SMARCA4突变 SWI/SNF复合体 预后 免疫组织化学检测
暂未订购
Menin抑制剂治疗NPM1突变急性髓系白血病的研究进展
14
作者 于晓达 李佳璟 +2 位作者 王安安 郭建刚 刘蓓 《中国临床药理学与治疗学》 北大核心 2025年第4期533-540,共8页
核仁磷酸蛋白1(NPM1)突变是急性髓系白血病(AML)最常见的突变之一,在合并FLT3内部串联重复(FLT3-ITD)和/或DNMT3A共突变或伴不良细胞遗传学等条件下会使原本较好的预后变差。近年来,研究发现靶向Menin-KMT2A复合物的多发性内分泌腺瘤蛋... 核仁磷酸蛋白1(NPM1)突变是急性髓系白血病(AML)最常见的突变之一,在合并FLT3内部串联重复(FLT3-ITD)和/或DNMT3A共突变或伴不良细胞遗传学等条件下会使原本较好的预后变差。近年来,研究发现靶向Menin-KMT2A复合物的多发性内分泌腺瘤蛋白(Menin)抑制剂在NPM1突变的AML(NPM1m-AML)中可以抑制致白血病基因HOX(homeotic gene)和MEIS1(myeloid ecotropic viral integration site 1)基因的过表达,体现出显著的抗白血病活性。本文将对新型小分子靶向药物Menin抑制剂在NPM1m-AML的作用机制、临床研究以及Menin抑制剂的耐药机制进行综述,希望为NPM1m-AML患者提供更有前景的治疗方案。 展开更多
关键词 急性髓系白血病 Menin抑制剂 NPM1突变 Menin-KMT2A复合物
暂未订购
SWI/SNF染色质重塑复合物在肿瘤耐药中的作用 被引量:1
15
作者 朱桂珍 叶巧 +7 位作者 罗渊 彭洁 王璐 杨昭婷 段峰森 郭丙乾 梅竹松 王广云 《生物化学与生物物理进展》 北大核心 2025年第1期20-31,共12页
肿瘤耐药是化疗和靶向药物治疗面临的重要问题,它是一个涉及染色质重塑的复杂过程。SWI/SNF是肿瘤发生中研究最多的ATP依赖性染色质重塑复合物之一,在染色质结构稳定性、基因表达和翻译后修饰的协调过程中起着重要作用,但其调控肿瘤耐... 肿瘤耐药是化疗和靶向药物治疗面临的重要问题,它是一个涉及染色质重塑的复杂过程。SWI/SNF是肿瘤发生中研究最多的ATP依赖性染色质重塑复合物之一,在染色质结构稳定性、基因表达和翻译后修饰的协调过程中起着重要作用,但其调控肿瘤耐药的机制尚未被系统梳理。SWI/SNF按其亚基组成可分为BAF、PBAF和ncBAF 3种,这3种亚型均包含ATP酶催化亚基、核心亚基和调节亚基,可以通过调控染色质结构来控制基因表达。SWI/SNF复合物亚基的改变是调控肿瘤耐药和进展的重要因素之一,充分了解该复合物在肿瘤耐药中的分子机制可以改善癌症的治疗。本文总结了SWI/SNF复合物的组成、引起肿瘤耐药的突变或异常表达亚基类型、主要的耐药机制以及肿瘤耐药的克服方法等,为临床上SWI/SNF亚基突变或异常表达引起的肿瘤预后不良的诊断和治疗提供了思路。 展开更多
关键词 SWI/SNF染色质重塑复合物 亚基突变 肿瘤耐药
原文传递
一种面向复杂电磁环境的试验资源调度优化算法
16
作者 姜艳霞 郭国君 +2 位作者 郭海亮 张维 杜明 《无线电工程》 2025年第8期1640-1649,共10页
针对电磁试验场环境存在不确定性、多变性、多样性等特点,导致复杂电磁环境中试验场区用频设备的空间、时间、频谱试验资源调度困难的问题,提出了一种面向复杂电磁环境的试验资源调度优化算法——CVSPSO。利用布局方案的多种影响因素构... 针对电磁试验场环境存在不确定性、多变性、多样性等特点,导致复杂电磁环境中试验场区用频设备的空间、时间、频谱试验资源调度困难的问题,提出了一种面向复杂电磁环境的试验资源调度优化算法——CVSPSO。利用布局方案的多种影响因素构建适应度函数,结合所提出的多维相似度计算以及基于自适应相似度阈值的凝聚式层次聚类算法提高局部多样性。在此基础上,提出一种改进的高斯变异方法,进一步提高种群随机多样性。在标准测试函数以及Unreal Engine 4(UE4)仿真电磁试验环境的用频设备上验证了方法的效果。实验结果表明,所提方法在大多数指标上均优于对比方法,能够为复杂电磁环境的试验资源调度提供优化布局方案,满足电子试验场空间布局与资源调度需求。 展开更多
关键词 复杂电磁环境 多维相似度 凝聚式层次聚类算法 自适应相似度阈值 交叉变异运算
在线阅读 下载PDF
Bayesian Analysis of Complex Mutations in HBV, HCV,and HIV Studies 被引量:2
17
作者 Bing Liu Shishi Feng +1 位作者 Xuan Guo Jing Zhang 《Big Data Mining and Analytics》 2019年第3期145-158,共14页
In this article,we aim to provide a thorough review of the Bayesian-inference-based methods applied to Hepatitis B Virus(HBV),Hepatitis C Virus(HCV),and Human Immunodeficiency Virus(HIV)studies with a focus on the det... In this article,we aim to provide a thorough review of the Bayesian-inference-based methods applied to Hepatitis B Virus(HBV),Hepatitis C Virus(HCV),and Human Immunodeficiency Virus(HIV)studies with a focus on the detection of the viral mutations and various problems which are correlated to these mutations.It is particularly difficult to detect and interpret these interacting mutation patterns,but by using Bayesian statistical modeling,it provides a groundbreaking opportunity to solve these problems.Here we summarize Bayesian-based statistical approaches,including the Bayesian Variable Partition(BVP)model,Bayesian Network(BN),and the Recursive Model Selection(RMS)procedure,which are designed to detect the mutations and to make further inferences to the comprehensive dependence structure among the interactions.BVP,BN,and RMS in which Markov Chain Monte Carlo(MCMC)methods are used have been widely applied in HBV,HCV,and HIV studies in the recent years.We also provide a summary of the Bayesian methods’applications toward these viruses’studies,where several important and useful results have been discovered.We envisage the applications of more modified Bayesian methods to other infectious diseases and cancer cells that will be following with critical medical results before long. 展开更多
关键词 Bayesian analysis HEPATITIS B Virus(HBV) HEPATITIS C Virus(HCV) Human Immunodeficiency Virus(HIV) complex mutationS Markov chain Monte Carlo
原文传递
消化系统SWI/SNF复合物缺失性癌31例临床病理学分析
18
作者 卓帅帅 方海生 +3 位作者 龚予希 陈刚 白茹梦 张智弘 《南京医科大学学报(自然科学版)》 北大核心 2025年第12期1775-1783,共9页
目的:探讨消化系统酵母交配型转换/蔗糖不发酵(switch/sucrose non-fermentable complex,SWI/SNF)染色质重塑复合物缺失性癌的临床病理学特征、免疫表型、分子遗传学改变特点,并分析其诊断及鉴别诊断要点。方法:收集31例消化系统SWI/SN... 目的:探讨消化系统酵母交配型转换/蔗糖不发酵(switch/sucrose non-fermentable complex,SWI/SNF)染色质重塑复合物缺失性癌的临床病理学特征、免疫表型、分子遗传学改变特点,并分析其诊断及鉴别诊断要点。方法:收集31例消化系统SWI/SNF复合物缺失性癌患者的临床资料,观察其组织学形态,总结免疫组织化学结果和分子改变特点,并复习相关文献进行分析。结果:31例患者中,男19例,女12例,年龄43~80岁,中位年龄66岁。病灶位于食管下段(胃食管交界处)1例,胃7例,右半结肠3例,胰腺18例,肝胰壶腹部2例。病灶最大径1.5~18.0 cm(中位数3.5 cm)。组织学上,15例肿瘤呈未分化癌形态,16例为低到中分化胰腺导管腺癌、腺鳞癌或导管内乳头状黏液性肿瘤(intraductal papillary mucinous neoplasm,IPMN)伴相关浸润性癌。免疫表型上,15例未分化癌中14例显示BRG1失表达,1例胰腺未分化癌出现INI1部分缺失性表达,而BRG1保留表达;4例肿瘤细胞CK-pan表达阴性或仅散在表达,其他上皮性标志物仅见个别肿瘤细胞阳性或多为阴性;7例部分肿瘤细胞Syn表达弱到中等阳性,其中2例分别见散在的CD56或INSM1弱阳性,CgA全部为阴性。16例胰腺/壶腹部癌BRG1保留表达,8例INI1部分失表达或表达减弱,8例保留表达;分子病理显示,14例出现了SMARCB1基因突变,2例出现SMARCA4基因突变,所有病例均可见KRAS基因突变,14例出现TP53基因突变。结论:消化系统SWI/SNF复合物缺失性癌部分为未分化癌,没有特定的分化特征,胃肠道外SWI/SNF复合物缺失性癌可能更多出现不同分化程度的腺癌形态,提示行BRG1和INI1等SWI/SNF蛋白检测可减少漏诊和误诊。胰腺癌中SWI/SNF相关基因突变与KRAS和TP53基因突变具有相关性。 展开更多
关键词 消化系统肿瘤 SWI/SNF复合物 临床病理学特征 KRAS突变
原文传递
Malignancy of renal angiomyolipoma from tuberous sclerosis complex with TSC2 mutation
19
作者 Yu-Jing Huang Zong-Pei Jiang +4 位作者 Yu-Ping Chen Jin-Quan Wu Jia-Li Huang Yan-Qiang Chen Meng-Jun Liang 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第1期103-105,共3页
To the Editor:Tuberous sclerosis complex (TSC),with the birth incidence of 1:6000,[1] is an autosomal dominant inherited,multi-system disorder characterized by cellular hyperplasia and tissue dysplasia,among which,ren... To the Editor:Tuberous sclerosis complex (TSC),with the birth incidence of 1:6000,[1] is an autosomal dominant inherited,multi-system disorder characterized by cellular hyperplasia and tissue dysplasia,among which,renal angiomyolipoma (AML) is one common comorbidity.However,malignancy of renal AML is rare.Herein,we shared a case of malignancy of renal AML from TSC in a young man. 展开更多
关键词 MALIGNANCY RENAL ANGIOMYOLIPOMA tuberous SCLEROSIS complex TSC2 mutation
原文传递
p53S通过DREAM/MMB通路调控Werner综合征细胞端粒DNA复制及延伸
20
作者 杨俊 王倩倩 +1 位作者 姜良霞 罗瑛 《贵州医科大学学报》 2025年第6期781-791,共11页
目的研究抑癌基因TP53(tumor protein 53,TP53)突变后编码的蛋白(p53N236S,p53S)通过下游调节元件拮抗调节剂/髓细胞组织增生病毒癌基因同源物-多细胞B类复合物(DP,RB-like,E2F,and MuvB complex/Myb-MuvB complex,DREAM/MMB)通路对Wer... 目的研究抑癌基因TP53(tumor protein 53,TP53)突变后编码的蛋白(p53N236S,p53S)通过下游调节元件拮抗调节剂/髓细胞组织增生病毒癌基因同源物-多细胞B类复合物(DP,RB-like,E2F,and MuvB complex/Myb-MuvB complex,DREAM/MMB)通路对Werner综合征(werner syndrome,WS)细胞端粒DNA复制的调控作用及其机制。方法以引入p53S突变的第五代WS小鼠胚胎成纤维细胞(G5TM)为研究对象,以野生型(WT)、第五代WS小鼠(G5DM)及敲除p53的第五代WS小鼠(G5TKO)胚胎成纤维细胞为对照,蛋白印记法(Western blot)检测各组细胞中DREAM/MMB相关蛋白和细胞周期相关蛋白的表达,染色质免疫沉淀法(Co-IP)检测各组细胞中DREAM/MMB通路调控关键蛋白与其相互作用蛋白的结合;染色质免疫沉淀法(ChIP)检测三种基因型细胞中(WT、G5DM、G5TM)p53与DAERM/MMB通路基因启动子的结合情况,免疫荧光-荧光原位杂交技术法(immunofluorescence-fluorescence in situ hybridization,IF-FISH)检测各组细胞中DNA解旋酶和端粒保护蛋白以及DNA损伤标志蛋白同端粒信号的共定位情况,端粒DNA实时荧光定量聚合酶链反应(quantitative real-time polymerase chain reaction,qPCR)检测各组细胞端粒的相对长度。结果Western blot结果表明,在G5TM细胞中p53S蛋白表达显著上调,下游靶基因p21在G5TM及G5KO细胞中表达被抑制(P<0.05);通过对比WT、G5DM及G5TKO细胞,发现p53S特异性激活DREAM/MMB复合体通路,关键组分B-Myb、FoxM1、p130、p-Rb、Lin54、Lin9和E2f1的表达均被上调(P<0.05);Co-IP实验揭示,p53S通过增强Lin9与p130及B-Myb的相互作用,促进DREAM/MMB复合体的功能重构;ChIP分析证实,p53能直接结合Lin54、Lin9、Mybl2和Rbl2的启动子区域,其结合强度高于WT及G5DM,提示其通过转录调控激活这些基因(P<0.05),同时p53S上调Cdc25c及CDK1/2/4/6等蛋白的表达,协同推动细胞周期进程(P<0.05);IF-FISH结果显示,p53S促进Recql4、Blm、Terf1和Pot1a与端粒DNA的共定位,并增强端粒信号强度(P<0.05),而G5DM及G5TKO细胞中ATR在端粒区异常聚集,表明p53S通过招募保护因子维持端粒完整性;端粒qPCR证实p53S可恢复端粒复制能力(P<0.05),提示其通过激活增殖通路与端粒保护机制协同促进细胞端粒的延伸。结论p53S的引入可以上调DNA解旋酶、端粒保护蛋白并招募到端粒DNA,缓解WS所造成的端粒复制压力,有利于端粒的延伸。 展开更多
关键词 WERNER综合征 p53S突变 DREAM/MMB DNA解旋酶 端粒
暂未订购
上一页 1 2 10 下一页 到第
使用帮助 返回顶部